Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3827 ARTÍCULOS , VIENDO DEL 931 AL 945

Lysosomal impairment in Parkinson's disease

Dehay B, Martinez-Vicente M, Caldwell GA, Caldwell KA, Yue Z, Cookson MR, Klein C, Vila M, Bezard E.

Mov Disord. 2013 Jun;28(6):725-32. doi: 10.1002/mds.25462. Epub 2013 Apr 11.

Designing a new scale to measure anxiety symptoms in Parkinson's disease: item selection based on canonical correlation analysis

Martinez-Martin P, Rojo-Abuin JM, Dujardin K, Pontone GM, Weintraub D, Forjaz MJ, Starkstein S, Leentjens AF.

Eur J Neurol. 2013 Aug;20(8):1198-203. doi: 10.1111/ene.12160. Epub 2013 Apr 14.

Genetic susceptibility testing for neurodegenerative diseases: ethical and practice issues

Roberts JS, Uhlmann WR.

Prog Neurobiol. 2013 Nov;110:89-101. doi: 10.1016/j.pneurobio.2013.02.005. Epub 2013 Apr 9.

Cognitive dysfunction and REM sleep behavior disorder: key findings in the literature and preliminary longitudinal findings

Manni R, Sinforiani E, Pacchetti C, Zucchella C, Cremascoli R, Terzaghi M.

Int J Psychophysiol. 2013 Aug;89(2):213-7. doi: 10.1016/j.ijpsycho.2013.04.003. Epub 2013 Apr 11.

α4β2 Nicotinic receptors play a role in the nAChR-mediated decline in L-dopa-induced dyskinesias in parkinsonian rats

Quik M, Campos C, Bordia T, Strachan JP, Zhang J, McIntosh JM, Letchworth S, Jordan K.

Neuropharmacology. 2013 Aug;71:191-203. doi: 10.1016/j.neuropharm.2013.03.038. Epub 2013 Apr 12.

A systematic review of biomarkers for disease progression in Parkinson's disease

McGhee DJ, Royle PL, Thompson PA, Wright DE, Zajicek JP, Counsell CE.

BMC Neurol. 2013 Apr 12;13:35. doi: 10.1186/1471-2377-13-35.

A neuroprosthesis for tremor management through the control of muscle co-contraction

Gallego JÁ, Rocon E, Belda-Lois JM, Pons JL.

J Neuroeng Rehabil. 2013 Apr 15;10:36. doi: 10.1186/1743-0003-10-36.

α-Synuclein: the long distance runner

George S, Rey NL, Reichenbach N, Steiner JA, Brundin P.

Brain Pathol. 2013 May;23(3):350-7. doi: 10.1111/bpa.12046.

Non-motor symptoms in Parkinson's disease

Barbosa ER.

Arq Neuropsiquiatr. 2013 Apr;71(4):203-4. doi: 10.1590/0004-282x20130001.

The role of neuroplasticity in dopaminergic therapy for Parkinson disease

Zhuang X, Mazzoni P, Kang UJ.

Nat Rev Neurol. 2013 May;9(5):248-56. doi: 10.1038/nrneurol.2013.57. Epub 2013 Apr 16.

A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies

Nalls MA, Duran R, Lopez G, Kurzawa-Akanbi M, McKeith IG, Chinnery PF, Morris CM, Theuns J, Crosiers D, Cras P, Engelborghs S, De Deyn PP, Van Broeckhoven C, Mann DM, Snowden J, Pickering-Brown S, Halliwell N, Davidson Y, Gibbons L, Harris J, Sheerin UM, Bras J, Hardy J, Clark L, Marder K, Honig LS, Berg D, Maetzler W, Brockmann K, Gasser T, Novellino F, Quattrone A, Annesi G, De Marco EV, Rogaeva E, Masellis M, Black SE, Bilbao JM, Foroud T, Ghetti B, Nichols WC, Pankratz N, Halliday G, Lesage S, Klebe S, Durr A, Duyckaerts C, Brice A, Giasson BI, Trojanowski JQ, Hurtig HI, Tayebi N, Landazabal C, Knight MA, Keller M, Singleton AB, Wolfsberg TG, Sidransky E.

JAMA Neurol. 2013 Jun;70(6):727-35. doi: 10.1001/jamaneurol.2013.1925.

Glucocerebrosidase mutations: tipping point toward Parkinson disease and dementia?

Klein C, Krainc D.

JAMA Neurol. 2013 Jun;70(6):686-8. doi: 10.1001/jamaneurol.2013.87.

Parkinson's disease: an update on pathogenesis and treatment

Foltynie T, Kahan J.

J Neurol. 2013 May;260(5):1433-40. doi: 10.1007/s00415-013-6915-1. Epub 2013 Apr 16.

Neuronal vulnerability, pathogenesis, and Parkinson's disease

Sulzer D, Surmeier DJ.

Mov Disord. 2013 Jun;28(6):715-24. doi: 10.1002/mds.25187. Epub 2013 Apr 15.

Long-term safety and efficacy of preladenant in subjects with fluctuating Parkinson's disease

Factor SA, Wolski K, Togasaki DM, Huyck S, Cantillon M, Ho TW, Hauser RA, Pourcher E.

Mov Disord. 2013 Jun;28(6):817-20. doi: 10.1002/mds.25395. Epub 2013 Apr 15.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias